Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$6M+14.4% YoY

Gross Profit

$3M52.5% margin

Operating Income

-$7M-119.8% margin

Net Income

-$7M-118.5% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

+9.5%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$48M

Total Liabilities

$20M

Stockholders' Equity

$27M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+14.4%
Gross Profit	$3M	$3M	-4.0%
Operating Income	-$7M	-$4M	-69.6%
Net Income	-$7M	-$4M	-63.9%

Revenue Segments

Biologics And Drug Delivery

$3M38%

Functional Neurosurgery Navigation and Therapy

$2M25%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M20%

Functional Neurosurgery Navigation and Therapy - Services

$383,0004%

Capital Equipment And Software

$381,0004%

Biologics And Drug Delivery - Disposable Products

$346,0004%

Capital Equipment And Software - Services

$208,0002%

Capital Equipment And Software - Systems and Software Products

$173,0002%